Home » Stocks » MannKind Corporation

MannKind Corporation (MNKD)

Stock Price: $2.05 USD -0.05 (-2.38%)
Updated Oct 23, 2020 4:00 PM EDT - Market closed
After-hours: $2.07 +0.02 (0.98%) Oct 23, 7:58 PM

Stock Price Chart

Key Info

Market Cap 469.81M
Revenue (ttm) 61.94M
Net Income (ttm) -44.21M
Shares Out 229.18M
EPS (ttm) -0.21
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Oct 23, 2020
Last Price $2.05
Previous Close $2.10
Change ($) -0.05
Change (%) -2.38%
Day's Open 2.14
Day's Range 1.98 - 2.14
Day's Volume 1,679,210
52-Week Range 0.80 - 2.48

More Stats

Market Cap 469.81M
Enterprise Value 529.86M
Earnings Date (est) Nov 4, 2020
Ex-Dividend Date n/a
Shares Outstanding 229.18M
Float 215.32M
EPS (basic) -0.21
EPS (diluted) -0.21
FCF / Share -0.34
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 26.36M
Short Ratio 12.17
Short % of Float 12.24%
Beta 2.10
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 7.59
PB Ratio n/a
Revenue 61.94M
Operating Income -36.32M
Net Income -44.21M
Free Cash Flow -73.43M
Net Cash -60.05M
Net Cash / Share -0.26
Gross Margin 56.60%
Operating Margin -58.64%
Profit Margin -71.40%
FCF Margin -118.56%
ROA -23.32%
ROE n/a
ROIC -29.70%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (5)

Buy 5
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

(46.34% upside)
Current: $2.05
Target: 3.00
*Average 12-month price target from 5 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Revenue Growth126.28%137.2%-93.28%-----30%-46.24%-
Gross Profit35.067.39-5.48125-64.75--
Operating Income-46.51-81.06-94.5563.83-342-180-169-147-141-152
Net Income-51.90-86.98-117126-368-198-191-169-161-171
Shares Outstanding19614410492.0581.2377.0559.9236.1724.3622.73
Earnings Per Share-0.27-0.60-1.131.36-4.54-2.57-3.20-4.70-6.60-7.50
Operating Cash Flow-88.48-37.73-64.78-78.09-57.234.09-129-120-124-149
Capital Expenditures-2.57-0.230.02-1.13-10.20-24.10-7.99-0.56-6.77-9.54
Free Cash Flow-91.05-37.97-64.75-79.22-67.44-20.01-137-120-131-158
Cash & Equivalents50.2071.6848.3622.9059.0712170.7961.842.6870.43
Total Debt121102157148214225250332488445
Net Cash / Debt-71.21-30.80-108-126-155-104-179-270-485-374
Book Value-191-175-215-184-350-73.77-30.71-111-314-186
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name MannKind Corporation
Country United States
Employees 232
CEO Michael E. Castagna

Stock Information

Ticker Symbol MNKD
Stock Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Unique Identifier NASDAQ: MNKD
IPO Date July 28, 2004


MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for diabetes and pulmonary arterial hypertension patients in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. The company has a license and collaboration agreement with United Therapeutics Corporation for the development and commercialization of a dry powder formulation of treprostinil used for the treatment of pulmonary arterial hypertension. MannKind Corporation was founded in 1991 and is headquartered in Westlake Village, California.